-
TCCI® Opens First “Chen Frontier Lab for Brain Research” in Shanghai
On October 23, 2020, Tianqiao and Chrissy Chen Institute (TCCI®)’s first Frontier Lab for Brain Research was put into operation at Shanghai Huashan Hospital Hongqiao Campus, a large-scale neuroscience medical center. The new lab works on multiple fields of research, including the brain-machine interface, sleep and dreams, cognitive assessment, and digital medicine. It prioritizes the […]
-
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
Cohen Veterans Bioscience (CVB), a non-profit research biotech advancing brain health solutions, today announces findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment. The study, entitled […]
-
Focal Epilepsy Often Overlooked
Having subtler symptoms, a form of epilepsy that affects only one part of the brain often goes undiagnosed long enough to cause unexpected seizures that contribute to car crashes, a new study finds. The study, published online October 20 in the journal Epilepsia, addressed focal epilepsy, the most common form of this brain disorder. Researchers […]
-
Targeted delivery of anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta. Christopher Power, a professor in the Faculty of Medicine & Dentistry, and Leina Saito, a graduate student on his team, showed that delivering an anti-inflammatory drug to mice […]
-
New research reveals why low oxygen damages the brain
Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at Case Western Reserve University School of Medicine. “These powerful protein responders initially protect brain cells from low oxygen as expected, but we […]
-
Could Reducing Painful Procedures Help Premature Infants’ Brains?
Premature infants born earlier than 28 weeks gestation who experience fewer needle pokes while receiving life-saving care in the neonatal intensive care unit may have better growth of a part of the brain called the thalamus. The new study is published in the October 21, 2020, online issue of Neurology®, the medical journal of the […]
-
Community Noise May Affect Dementia Risk
Researchers studied 5,227 participants of the Chicago Health and Aging Project who were aged 65 years or older, of whom 30% had mild cognitive impairment and 11% had Alzheimer’s disease. They found that persons living with 10 decibels more noise near their residences during the daytime had a 36% higher odds of having mild cognitive […]
-
Scientists Take Major Step Toward Angelman Syndrome Gene Therapy
Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures […]
-
Diagnosing Parkinson’s disease with skin samples could lead to earlier detection
New research shows a simple skin test can accurately identify Parkinson’s disease, demonstrating for the first time the feasibility of the method. Currently diagnosed by clinical signs and symptoms but only definitively diagnosed at autopsy, Parkinson’s disease is commonly misdiagnosed early in the disease course, complicating clinical trials of potential treatments. The study, published in […]
-
Mayo Clinic contributes to diagnostic, therapeutic advance for rare neurodegenerative disorder
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3) ― a disease that has no cure. They also have clarified the role of a gene target associated with the disease. The inherited disease is linked to a mutation in the ATXN3 […]